scispace - formally typeset
Y

Yu Feng

Researcher at Oklahoma State University–Stillwater

Publications -  125
Citations -  18217

Yu Feng is an academic researcher from Oklahoma State University–Stillwater. The author has contributed to research in topics: Antibody & Heat transfer. The author has an hindex of 35, co-authored 95 publications receiving 16791 citations. Previous affiliations of Yu Feng include Jilin University & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

TL;DR: A cofactor for HIV-1 (human immunodeficiency virus-type 1) fusion and entry was identified with the use of a novel functional complementary DNA (cDNA) cloning strategy that is a putative G protein-coupled receptor with seven transmembrane segments.
Journal Article

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein–Coupled Receptor

TL;DR: Fusin this article is a putative G protein-coupled receptor with seven transmembrane segments, which enabled CD4-expressing nonhuman cell types to support HIV-1 Env-mediated cell fusion and infection.
Journal ArticleDOI

CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1

TL;DR: Recombinant CC CKR5, a G protein-coupled receptor for these chemokines, rendered CD4-expressing nonhuman cells fusion-competent preferentially with macrophage-tropic Envs, and is thus a fusion cofactor for HIV-1 strains.
Journal ArticleDOI

Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1

TL;DR: Three broadly neutralizing antibodies are identified, isolated from an HIV-1–infected individual, that exhibited great breadth and potency of neutralization and were specific for the co-receptor CD4-binding site of the glycoprotein 120 (gp120), part of the viral Env spike.
Journal ArticleDOI

Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.

TL;DR: Blood from COVID-19 patients who have recently become virus-free and therefore were discharged was collected, and SARS-CoV-2-specific humoral and cellular immunity in 8 newly discharged patients was detected, and there was a strong correlation between neutralization antibody titers and the numbers of virus-specific T cells.